Synopsis The global Obstetric Ultrasonic Transducer market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Obstetric ultrasonic transducer is a specialized .....
SynopsisRespiratory and Anesthesia Disposables are medical devices designed for the treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma and sleep apnea etc. They are commonly used in most of the surgical procedures as well. .....
SynopsisMultiple-use dental dispensers, sometimes called dental “syringes” are devices used to deliver various dental products including impression materials, adhesives, dental composites , and endodontic (root canal) materials to a treatment site in the mouth. Multip.....
SynopsisThe global Cancer Genomic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Cancer Genomic Testing is estimated to incr.....
SynopsisIt is used for the connection and fixation of soft tissue and bone in shoulder joint, foot, ankle joint, elbow joint and knee joint surgery. Global Titanium Alloy Cable Anchor with Needles market is projected to reach US$ million in 2029, increasing from.....
Synopsis It is mainly used to detect endotoxins in injectable drugs, biological products and medical devices. They are also used in kidney dialysis centers and a wide range of other applications. Highlights The global Bacte.....
SynopsisA Handheld Vein Finder is a portable medical device that uses technology, such as near-infrared (NIR) light, to illuminate and visualize veins, assisting medical professionals in venipuncture procedures. Global Handheld Vein Finder market is projected to.....
Synopsis Pegfilgrastim, sold under the brand name Neulasta among others, is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim.It serves to stimulate the production .....
SynopsisTildrakizumab (trade name Ilumya (USA)/Ilumetri (European Union)) is a monoclonal antibody designed for the treatment of immunologically mediated inflammatory disorders. In the United States, it is approved for the treatment of moderate-to-severe plaque psoria.....
SynopsisThe global Glutamate Receptor Ionotropic NMDA 2B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Glutamate Receptor Ionotropi.....
